Abstract
Cost analysis of schistosomiasis is important both in assessing the economic impact of the disease and in identifying the most cost-effective approaches to control. Economic impact has been examined both within and without the health sector, but there is a lack of measurement of the effects of disease, or the threat of disease, on patterns of production and community development. The cost-effectiveness of control approaches has been examined empirically and by using static models. Future analyses require a stronger epidemiological basis incorporating realistic demography and the temporal dynamics of reinfection, and assessment of outcomes in terms of disease rather than infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transactions of the Royal Society of Tropical Medicine and Hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
